logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Ryan, Christopher John
    Born in September 1948
    Individual (2 offsprings)
    Officer
    2021-01-04 ~ now
    OF - Director → CIF 0
  • 2
    Ryan, Thomas Edward
    Born in December 1977
    Individual (7 offsprings)
    Officer
    2021-01-04 ~ now
    OF - Director → CIF 0
    Mr Thomas Edward Ryan
    Born in December 1977
    Individual (7 offsprings)
    Person with significant control
    2021-01-04 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

EQUA PHARMA HOLDINGS LIMITED

Period: 2021-01-04 ~ now
Company number: 13111750
Registered name
EQUA PHARMA HOLDINGS LIMITED - now
Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Par Value of Share
Class 1 ordinary share
12024-02-01 ~ 2025-01-31
Fixed Assets - Investments
100 GBP2025-01-31
100 GBP2024-01-31
Investment Property
215,755 GBP2025-01-31
215,755 GBP2024-01-31
Fixed Assets
215,855 GBP2025-01-31
215,855 GBP2024-01-31
Creditors
Current
31,088 GBP2025-01-31
39,608 GBP2024-01-31
Net Current Assets/Liabilities
-31,088 GBP2025-01-31
-39,608 GBP2024-01-31
Total Assets Less Current Liabilities
184,767 GBP2025-01-31
176,247 GBP2024-01-31
Equity
Called up share capital
200 GBP2025-01-31
200 GBP2024-01-31
Retained earnings (accumulated losses)
184,567 GBP2025-01-31
176,047 GBP2024-01-31
Equity
184,767 GBP2025-01-31
176,247 GBP2024-01-31
Average Number of Employees
22024-02-01 ~ 2025-01-31
22023-02-01 ~ 2024-01-31
Investments in Group Undertakings
Cost valuation
100 GBP2024-01-31
Investments in Group Undertakings
100 GBP2025-01-31
100 GBP2024-01-31
Investment Property - Fair Value Model
215,755 GBP2024-01-31
Amounts owed to group undertakings
Current
29,090 GBP2025-01-31
37,386 GBP2024-01-31
Other Taxation & Social Security Payable
Current
1,998 GBP2025-01-31
2,222 GBP2024-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
200 shares2025-01-31

Related profiles found in government register
  • EQUA PHARMA HOLDINGS LIMITED
    Info
    Registered number 13111750
    22 Holly Bank Road, Huddersfield, West Yorkshire HD3 3LX
    PRIVATE LIMITED COMPANY incorporated on 2021-01-04 (5 years 6 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-01-03
    CIF 0
  • EQUA PHARMA HOLDINGS LIMITED
    S
    Registered number 13111750
    22, Holly Bank Road, Huddersfield, England, HD3 3LX
    Limited Company in England And Wales, United Kingdom
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    EQUA PHARMA LIMITED
    04056371
    22 Holly Bank Road, Huddersfield, West Yorkshire
    Active Corporate (6 parents)
    Person with significant control
    2021-08-18 ~ now
    CIF 1 - Ownership of voting rights - 75% or more OE
    CIF 1 - Ownership of shares – 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.